Genetic and pharmacological transcriptional upregulation of the repressed FXN gene as a… Grant US-11873494-B2 United States of America 16 Jan 2024
BONE MARROW ORGANOIDS PRODUCED FROM INDUCED PLURIPOTENT STEM CELLS AND USES OF THESE… Application WO-2023194370-A1 World Intellectual Property Organisation (WIPO) 12 Oct 2023
Blood type O Rh-hypo-immunogenic pluripotent cells Grant US-11162079-B2 United States of America 02 Nov 2021
CARDIOMYOCYTE PURIFICATION METHOD Application WO-2021187601-A1 World Intellectual Property Organisation (WIPO) 23 Sep 2021
Genetic and pharmacological transcriptional upregulation of the repressed FXN gene as a… Grant US-11124795-B2 United States of America 21 Sep 2021
Induced pluripotent cell-derived oligodendrocyte progenitor cells for the treatment of… Grant US-10626369-B2 United States of America 21 Apr 2020
Chemically defined albumin-free conditions for cardiomyocyte differentiation of human… Grant US-9765299-B2 United States of America 19 Sep 2017
CONTROLLED CELL DELIVERY VEHICLE AND TREATMENT OF TUMOURS Application WO-2016207638-A1 World Intellectual Property Organisation (WIPO) 29 Dec 2016
CELL MODIFICATION AND APPLICATION IN THERAPY Application WO-2016207637-A1 World Intellectual Property Organisation (WIPO) 29 Dec 2016
Chemically defined production of cardiomyocytes from pluripotent stem cells Application US-9234176-B2 United States of America 12 Jan 2016
DIRECTED CARDIOMYOCYTE DIFFERENTIATION OF STEM CELLS Application WO-2013063305-A3 World Intellectual Property Organisation (WIPO) 18 Jun 2015
PROMOTER OF DIFFERENTIATION OF PLURIPOTENT STEM CELL INTO MYOCARDIUM, WHICH COMPRISES EGF… Application WO-2014136519-A1 World Intellectual Property Organisation (WIPO) 12 Sep 2014
METHODS FOR MAKING AND USING MODIFIED OOCYTES Application WO-2014089363-A1 World Intellectual Property Organisation (WIPO) 12 Jun 2014